Talkiatry Secures $210M in Oversubscribed Series D to Expand Nationwide Psychiatry Platform
HEALTH & BEAUTY
Talkiatry cofounders Robert Krayn, CEO, and Dr. Georgia Gaveras, Chief Medical Officer. (Photo: Katy Andrascik).
Finding a psychiatrist in America has never been easy. Wait times stretch for months, insurance networks are limited, and continuity of care is rare. Talkiatry is building a different model, and investors just backed it with $210 million in Series D funding to prove the approach can scale nationally.
The oversubscribed round was led by Perceptive Advisors, with participation from Sofina and returning investors Andreessen Horowitz, blisce/, and Left Lane Capital. Including a debt facility from Banc of California, Talkiatry has now raised over $400 million.
A Different Kind of Provider Group
Talkiatry is the nation's largest private employer of psychiatrists, with more than 800 full-time clinicians on staff. The company has delivered 3 million patient visits to date and is in-network with over 100 insurers covering 170 million lives. Since launching its Mindshare Partner Program in late 2023, Talkiatry has partnered with more than a third of the country's top 20 health systems and over 50 total systems.
What sets Talkiatry apart isn't just scale, it's outcomes. According to company data, 87% of anxiety patients and 86% of depression patients report symptom reduction after just two visits. Among those patients, 67% and 62% respectively report no longer having clinically significant symptoms. Early dropout rates are 60% lower than industry benchmarks, meaning patients stick with care longer and avoid escalating into higher-cost settings like emergency rooms or inpatient facilities.
Why Health Systems and Payers Are Choosing Talkiatry
Health systems face a persistent challenge: psychiatric care is in high demand, but supply is limited and fragmented. Many systems lack the infrastructure to deliver consistent, in-network psychiatric services at scale. Talkiatry has built that infrastructure.
The company operates on a proprietary AI-powered technology platform that automates administrative tasks, engages patients between visits, supports health systems in getting patients into care quickly, and enables innovative payment models with payers. This allows Talkiatry to maintain quality and consistency even as patient volume grows.
For payers, the value proposition is straightforward: better outcomes at lower cost. Talkiatry reports cost reductions reaching up to $700 per member per month by keeping patients engaged in outpatient care and reducing the need for more expensive interventions.
"Health systems, payers, and employers continue to choose Talkiatry as their psychiatry partner of record to deliver consistent, superior outcomes across their patient populations," said Robert Krayn, CEO and cofounder of Talkiatry. "This funding supports expansion into more complex care and deeper partnerships as institutional demand grows."
Clinician Satisfaction Drives Patient Outcomes
Talkiatry's model also addresses a critical issue in psychiatry: burnout. In the company's most recent clinician satisfaction survey, 90% of psychiatrists said they would recommend Talkiatry as a place to practice. Clinicians report 80% less burnout than the industry average, including lower emotional exhaustion and a stronger sense of personal accomplishment.
This matters because clinician well-being directly impacts patient care. Talkiatry reports therapeutic alliance ratings, a measure of the strength of the clinician-patient relationship, that are 22% higher than industry peers, with 92% of patients building strong rapport with their providers. The company's Net Promoter Score sits at 76, reflecting consistent patient satisfaction.
What Comes Next
The Series D capital will fuel Talkiatry's continued investment in technology and support expansion across the acuity spectrum, including treating more complex psychiatric conditions. As demand from health systems and payers grows, the company is positioning itself as the de facto in-network psychiatry partner for large institutions seeking reliable access and measurable outcomes.
"Talkiatry is setting the standard for how psychiatry is delivered and measured, with a proven national operating model centered on employed psychiatrists built upon a proprietary technology platform," said Krayn.
Talkiatry treats conditions including anxiety, bipolar disorder, depression, postpartum depression, OCD, and PTSD. The company was ranked among the fastest-growing companies in North America on the Deloitte Technology Fast 500™ in 2025 and has been repeatedly recognized by Fortune and Great Place to Work as one of the best companies to work for in the country.
For more information, visit talkiatry.com.